Problem statement: Answer the multiple choice question.
Question: Which compound exhibits a 14.668% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a: CCCn1cc(CN2CCc3ccc(NC(=O)C4CCCO4)cc3C2)c(C)n1
b: CCN(CC(=O)Nc1ccccc1OC)C(=O)c1ccc(NC(=O)c2cccs2)cc1
Answer: a. CCCn1cc(CN2CCc3ccc(NC(=O)C4CCCO4)cc3C2)c(C)n1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCCn1cc(CN2CCc3ccc(NC(=O)C4CCCO4)cc3C2)c(C)n1
CCCn1cc(CN2CCc3ccc(NC(=O)C4CCCO4)cc3C2)c(C)n1
N-[2-[(3-methyl-1-propylpyrazol-4-yl)methyl]-3,4-dihydro-1H-isoquinolin-7-yl]oxolane-2-carboxamide